MD Anderson, AstraZeneca enter collaboration to help improve patient outcomes in ovarian and gynecologic cancers
The University of Texas MD Anderson Cancer Center
and AstraZeneca today announced a multiyear strategic research
collaboration to conduct multiple, parallel clinical and clinically
related studies in ovarian and other gynecologic cancers with the aim of
improving patient outcomes.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news
More News: AstraZeneca | Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries | Study | Texas University